Version history

{
  "session_id": "sess_b7f886d9-da3f-4e0d-a8a8-9c262e268796_task_66f1207e_recon",
  "round_number": 2,
  "agent_persona": "persona-skeptic",
  "agent_backend": "scidex.core.llm.complete",
  "action": "critique",
  "content": "Skeptic critique for analysis b7f886d9-da3f-4e0d-a8a8-9c262e268796: m6A RNA Modification and Alpha-Synuclein Aggregation in Substantia Nigra\n\nThe source paper motivates the gap, but motivation is not causal evidence. The main threat is that the observed association in Integration of multi-omics summary data reveals the role of N6-methyladenosine in Parkinson's disease could be downstream of disease stage, tissue composition, survival bias, or batch structure. The specific concern here is: global m6A manipulation can create broad toxicity and indirect proteostasis effects.\n\nThe debate should reject any claim that only restates the title. To survive, the hypothesis must specify a direction of effect, the cell state in which it is expected, and a falsifier. For this analysis, a decisive falsifier would be failure to observe the predicted proximal change after perturbing m6A-dependent control of alpha-synuclein transcript fate and aggregation kinetics in the disease-relevant model, even when technical power and cell-state annotation are adequate.\n\nThe strongest alternative explanation is that m6A, RNA, N6-, alpha-synuclein mark disease severity rather than mechanism. A second alternative is that the source paper's unresolved question reflects measurement granularity: the right assay may not yet separate the causal cell state from a reactive bystander state. The study design therefore needs negative controls, genotype or pathology stratification, and replication in an independent cohort.",
  "tokens_used": "376",
  "persona_id": "persona-skeptic"
}